Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zenas BioPharma

Explore full profile

To transform the lives of patients living with autoimmune diseases

Waltham, United StatesFounded 2020Biotech & Life Sciences
Valuation $1.53B Market cap · 2026
Revenue $36M Latest reported FY
Total funding $100–500M Disclosed equity funding

About Zenas BioPharma

Zenas BioPharma is a global biopharmaceutical company focused on developing and commercializing immunology-based therapies for patients with autoimmune diseases. The company operates in the biopharmaceutical market, targeting patients in need of innovative treatments for autoimmune conditions. Zenas BioPharma's business model centers on advancing a deep pipeline of therapeutics through successful business development strategies and partnerships. The company generates revenue by developing and commercializing these therapies, aiming to bring transformative solutions to patients worldwide. Zenas BioPharma serves a diverse client base, including healthcare providers, patients, and research institutions, and leverages its experienced leadership team and network of business partners to drive operational excellence.

Source: Dealroom company data

At a glance

Founded
2020
Headquarters
Waltham, United States
Listing
IPO 2024
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Zenas BioPharma.

See all news

Investors

23 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A13 investors entered at this stage

Series B and later10 investors entered at this stage

  • Bristol-Myers Squibb
  • SR One
  • Norwest Venture Partners
  • Delos Capital
  • NEA
  • Federated Hermes
  • Pivotal BioVenture Partners
  • ArrowMark Partners
  • Royalty Pharma
  • Pharmakon Holdings

Talent

Book a demo to see the people
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇺🇸 United States92.5%
🇨🇭 Switzerland2.3%
🇨🇳 China2.3%
🇪🇸 Spain0.8%
🇫🇷 France0.8%
Top 5 of 7 shown
Web traffic by country
9.4K monthly visits
across markets
🇺🇸 United States76.6%
🇬🇧 United Kingdom8.5%
🇮🇳 India8.5%
🇨🇦 Canada6.4%
Top 4 markets shown

Patents

Estimated portfolio value
$117k

9 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zenas BioPharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zenas BioPharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles